Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$236.25 +3.24 (+1.39%)
As of: Oct 2, 2026 · 10:57 AM EDT

Jazz Pharmaceuticals (JAZZ) Net Equity Issued and Repurchased (2010 - 2026)

Updated

Jazz Pharmaceuticals (JAZZ) recorded Net Equity Issued and Repurchased of $22.7 million in Q2 2026, up 116.2% from $10.5 million a year earlier but down 31.0% from the prior quarter.

Analysis

Jazz Pharmaceuticals (JAZZ) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

On a TTM basis, Jazz Pharmaceuticals' Net Equity Issued and Repurchased came in at $141.46 million as of Jun 30, 2026, up 353.2% year-over-year; for FY2025, it was $107.86 million, up 422.4% from FY2024.

  • Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 1.6% (FY2020 to FY2025).
  • Across earlier years, Net Equity Issued and Repurchased came in at $20.65 million in FY2024 (-55.6%), $46.46 million in FY2023 (-52.6%), $98.02 million in FY2022 (-27.5%) and $135.26 million in FY2021 (+35.7%).
  • Quarterly Net Equity Issued and Repurchased has ranged from $17,000 in Q3 2024 to $85.19 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Net Equity Issued and Repurchased has increased for three consecutive quarters, with growth averaging 171.5% over the last six quarters.
  • Peak year-over-year performance for Net Equity Issued and Repurchased in the last five years was growth of 826.3% in Q4 2025, against a decline of 99.7% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $32.9 million (Q1 2026), $85.19 million (Q4 2025) and $677,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Jazz Pharmaceuticals 15.03 Bn 8.85 Bn 1.09 Bn 22.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.70 Mn
Mar 31, 2026 32.90 Mn
Dec 31, 2025 85.19 Mn
Sep 30, 2025 677,000.00
Jun 30, 2025 10.50 Mn
Mar 31, 2025 11.50 Mn
Dec 31, 2024 9.20 Mn
Sep 30, 2024 17,000.00
Jun 30, 2024 10.94 Mn
Mar 31, 2024 494,000.00
Dec 31, 2023 8.85 Mn
Sep 30, 2023 5.51 Mn
Jun 30, 2023 10.87 Mn
Mar 31, 2023 21.23 Mn
Dec 31, 2022 30.16 Mn
Sep 30, 2022 21.26 Mn
Jun 30, 2022 24.87 Mn
Mar 31, 2022 21.73 Mn
Dec 31, 2021 18.15 Mn
Sep 30, 2021 14.82 Mn
API Access

Jazz Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=JAZZ&period=max&api_key=YOUR_API_KEY